EOAI3402143

EOAI3402143
Item number Size Datasheet Manual SDS Delivery time Quantity Price
Cay43117-5 5 mg -

6 - 10 business days*

275.00€
Cay43117-10 10 mg -

6 - 10 business days*

440.00€
Cay43117-25 25 mg -

6 - 10 business days*

824.00€
Cay43117-50 50 mg -

6 - 10 business days*

1,372.00€
 
EOAI3402143 is an inhibitor of ubiquitin-specific protease 9X (USP9X), USP24, and USP5. It... more
Product information "EOAI3402143"
EOAI3402143 is an inhibitor of ubiquitin-specific protease 9X (USP9X), USP24, and USP5. It inhibits the catalytic domain of USP9X (IC50 = 1. µM). EOAI3402143 (5 µM) inhibits USP9X, USP24, and USP5 in MM.1S multiple myeloma cells. It inhibits the growth of vemurafenib-sensitive and -resistant A375 melanoma cells (IC50s = 1 µM). In vivo, EOAI3402143 (15 mg/kg) reduces tumor volume in MM.1S and A375 mouse xenograft models.. Solulibility: DMSO: Sparingly soluble: 1-10 mg/ml: .
Keywords: G9, 2E-cyano-3-(3,6-dichloro-2-pyridinyl)-N-[1-[4-[2-(4-morpholinyl)ethoxy]phenyl]butyl]-2-propenamide
Supplier: Cayman Chemical
Supplier-Nr: 43117

Properties

Application: USP9X/USP24/USP5 inhibitor
MW: 503.42 D
Formula: C25H28Cl2N4O3
Purity: >98%
Format: Solid

Database Information

CAS : 1699750-95-2| Matching products
KEGG ID : K11840 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: -20°C)
Signal Word: Warning
GHS Hazard Pictograms:
H Phrases: H302, H315, H319, H335
P Phrases: P261, P264, P270, P271, P280, P301+310, P302+352, P304+340, P305+351+338, P312, P321, P330, P332+313, P337+313, P362+364, P403+233, P405, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "EOAI3402143"
Write a review
or to review a product.
Viewed